Compare VERA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | LZB |
|---|---|---|
| Founded | 2016 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | N/A |
| Metric | VERA | LZB |
|---|---|---|
| Price | $49.71 | $39.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $67.67 | $42.50 |
| AVG Volume (30 Days) | ★ 1.8M | 696.4K |
| Earning Date | 11-05-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.16 |
| Revenue | N/A | ★ $2,107,357,000.00 |
| Revenue This Year | N/A | $2.36 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | ★ N/A | $18.33 |
| Revenue Growth | N/A | ★ 1.78 |
| 52 Week Low | $18.53 | $29.03 |
| 52 Week High | $50.09 | $48.31 |
| Indicator | VERA | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 83.43 | 66.21 |
| Support Level | $40.38 | $37.84 |
| Resistance Level | $47.10 | $40.75 |
| Average True Range (ATR) | 3.35 | 1.03 |
| MACD | 1.34 | -0.01 |
| Stochastic Oscillator | 99.33 | 75.18 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.